Recognizing a parallel in the obstacles to commercialization between the personalized medicine space and the microbiome field, the Arrowhead Translational Microbiome Conference was launched in 2014 with the goal of bringing together the leading microbiome companies and key thinkers in the field to discuss and determine how to best these hurdles.

Following a successful first conference, a small group of innovative, forward-thinking companies came together in the summer of 2015 to respond to a Request for Information by White House Office of Science and Technology Policy regarding the microbiome.

Through the process of drafting that response, these companies recognized the need for a coordinated effort to promote greater public understanding of the role of the microbiome in human health and wellness and create a greater power to engage the regulatory agencies, developing a cohesive voice for the microbiome industry. 

The following companies, through their corporate representatives, have provided initial funding to support the launch of The Microbiome Coalition (TMBC) and have generously provided their time and expertise in guiding its development.

AO Biome
Larry Weiss, MD, Chief Medical Office

Abbott Nutrition
JoMay Chow, Ph.D., Senior Research Scientist

CosmosID
Manoj Dadlani, CEO

Diversigen
Joseph F. Petrosino, Ph.D., Founder and Chief Scientific Officer

Mayo Clinic
Purna Kashyap, MBBS, Assistant Professor at Mayo Clinic
Kelly Krajnik, Business Development Manager

Second Genome
Mohan S. Iyer, Chief Business Officer

Whole Biome
Colleen Cutcliffe, Ph.D., CEO and Co-Founder